| __timestamp | Halozyme Therapeutics, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 35942000 | 17992000000 |
| Thursday, January 1, 2015 | 40028000 | 22400000000 |
| Friday, January 1, 2016 | 45853000 | 23910000000 |
| Sunday, January 1, 2017 | 53816000 | 23813000000 |
| Monday, January 1, 2018 | 60804000 | 24694000000 |
| Tuesday, January 1, 2019 | 77252000 | 23557000000 |
| Wednesday, January 1, 2020 | 45736000 | 25436000000 |
| Friday, January 1, 2021 | 50323000 | 24586000000 |
| Saturday, January 1, 2022 | 143526000 | 27295000000 |
| Sunday, January 1, 2023 | 149182000 | 34205000000 |
| Monday, January 1, 2024 | 154335000 | 28113000000 |
Unlocking the unknown
In the ever-evolving landscape of corporate finance, Selling, General, and Administrative (SG&A) expenses serve as a critical indicator of a company's operational efficiency. This analysis juxtaposes the SG&A trends of Walgreens Boots Alliance, Inc. and Halozyme Therapeutics, Inc. from 2014 to 2023.
Walgreens, a retail giant, consistently reported SG&A expenses exceeding $17 billion annually, peaking at approximately $28 billion in 2024. This steady increase reflects its expansive retail operations and strategic investments.
Conversely, Halozyme, a biopharmaceutical company, exhibited a more volatile SG&A trajectory. Starting at $36 million in 2014, expenses surged by over 300% to $149 million by 2023, highlighting its aggressive growth and R&D investments.
This comparison underscores the diverse financial strategies employed by companies in different sectors, with Walgreens focusing on scale and Halozyme on innovation.
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Breaking Down SG&A Expenses: Incyte Corporation vs Walgreens Boots Alliance, Inc.
Who Optimizes SG&A Costs Better? Incyte Corporation or Halozyme Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Walgreens Boots Alliance, Inc.
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Halozyme Therapeutics, Inc.
Walgreens Boots Alliance, Inc. vs TG Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Walgreens Boots Alliance, Inc. or Geron Corporation
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs BioCryst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Taro Pharmaceutical Industries Ltd.
Halozyme Therapeutics, Inc. vs Mesoblast Limited: SG&A Expense Trends